IMA
Price:
$6.78
Market Cap:
$75.81M
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
Industry
Biotechnology
IPO Date
1998-02-27
Stock Exchange
NASDAQ
Ticker
IMA
According to ImageneBio Inc’s latest financial reports and current stock price. The company's current Current Ratio is 13.52. This represents a change of 0.25% compared to the average of 13.49 of the last 4 quarters.
The mean historical Current Ratio of ImageneBio Inc over the last ten years is 7.87. The current 13.52 Current Ratio has changed 17.07% with respect to the historical average. Over the past ten years (40 quarters), IMA's Current Ratio was at its highest in in the June 2024 quarter at 18.22. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
7.87
Median
7.44
Minimum
3.51
Maximum
12.58
Discovering the peaks and valleys of ImageneBio Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.02%
Maximum Annual Current Ratio = 12.58
Minimum Annual Increase = -32.88%
Minimum Annual Current Ratio = 3.51
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 11.80 | -6.19% |
| 2023 | 12.58 | 69.02% |
| 2022 | 7.44 | -14.46% |
| 2021 | 8.70 | 48.50% |
| 2020 | 5.86 | 67.05% |
| 2019 | 3.51 | -32.88% |
The current Current Ratio of ImageneBio Inc (IMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.61
5-year avg
9.27
10-year avg
7.87
ImageneBio Inc’s Current Ratio is greater than Connect Biopharma Holdings Limited (7.24), greater than InflaRx N.V. (4.10), greater than Kalaris Therapeutics Inc (12.89), less than Shattuck Labs, Inc. (17.00), less than Context Therapeutics Inc. (19.04), greater than Sutro Biopharma, Inc. (2.53), greater than Artiva Biotherapeutics, Inc. (11.65), greater than Ovid Therapeutics Inc. (4.24), greater than Metagenomi, Inc. Common Stock (6.36), greater than Quince Therapeutics, Inc. (5.00),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.24 | $141.98M | |
| 4.10 | $74.52M | |
| 12.89 | $110.72M | |
| 17.00 | $142.27M | |
| 19.04 | $94.64M | |
| 2.53 | $79.86M | |
| 11.65 | $92.66M | |
| 4.24 | $115.21M | |
| 6.36 | $67.21M | |
| 5.00 | $200.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImageneBio Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ImageneBio Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ImageneBio Inc's Current Ratio?
How is the Current Ratio calculated for ImageneBio Inc (IMA)?
What is the highest Current Ratio for ImageneBio Inc (IMA)?
What is the 3-year average Current Ratio for ImageneBio Inc (IMA)?
What is the 5-year average Current Ratio for ImageneBio Inc (IMA)?
How does the current Current Ratio for ImageneBio Inc (IMA) compare to its historical average?